Puartion Inc Announces 30 Percent Stake in Cannabis Pharmaceutical Company Pursuing $50 Billion Market Opportunity
November 09 2018 - 8:41AM
InvestorsHub NewsWire
Dallas, TX – InvestorsHub NewsWire
-- November 9, 2018 Puration, Inc. (USOTC:
PURA) (“PURA”) today announced securing a thirty percent (30%)
interest in US Cannabis Health LLC, a new company established in
partnership with Kali, Inc. (USOTC:
KALY) (“KALY”) and Nouveau Life Pharmaceuticals, Inc. (USOTC:
NOUV) (“NOUV”). The three companies have each contributed
assets in exchange for respective 30% stakes in US Cannabis Health
which has been set up to develop cannabis pharmaceutical and
wellness therapies estimated to be a $50 Billion market by 2029. A reserve of 10%
equity is set aside for a US Cannabis Health management team yet to
be selected.
Hosted by PURA at their corporate
headquarters, management from the three companies met this week in
Dallas, Texas to finalize plans for US Cannabis Health. The
meetings were held in conjunction with KALY finalizing the acquisition of NCM
Biotech. KALY and NCM Biotech expect to
imminently make a formal announcement of the acquisition
closing.
An online presentation was recently released
detailing the contributions of each of the three corporations to US
Cannabis Health. The presentation included an overview of the
business plan for US Cannabis Health going
forward.
Learn
more about Puration at https://www.purationinc.com/
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"),
and as such, may involve risks and uncertainties. These forward
looking statements relate to, amongst other things, current
expectation of the business environment in which the company
operates, potential future performance, projections of future
performance and the perceived opportunities in the market. The
company's actual performance, results and achievements may differ
materially from the expressed or implied in such forward-looking
statements as a result of a wide range of
factors.
Puration,
Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Sep 2023 to Sep 2024